Hand Brace Management for Arthritis
For thumb base (first CMC joint) osteoarthritis, use a custom-made rigid or neoprene orthosis worn continuously for at least 3 months; for other finger joints, orthoses are conditionally recommended with weaker evidence. 1, 2
Type of Splint by Joint Location
First CMC (Thumb Base) Joint - STRONG RECOMMENDATION
- Custom-made rigid or neoprene orthoses are strongly recommended for first carpometacarpal joint osteoarthritis, as they provide superior fit and improve patient compliance compared to prefabricated devices. 1, 2
- The Push Ortho Thumb Brace CMC (a prefabricated option) demonstrates higher patient satisfaction and less interference with hand function compared to traditional custom-made orthoses, though both reduce pain similarly. 3
- Silicone wrist-hand orthoses show 77% improvement in daily functioning and 61% reduction in perceived pain, particularly for static and repetitive wrist-straining activities. 4
Other Hand Joints (DIP, PIP, MCP) - CONDITIONAL RECOMMENDATION
- Orthoses for joints other than the first CMC are conditionally recommended, as the evidence is less robust. 1
- Options include digital orthoses, ring splints, and gloves that provide warmth and compression. 1
- Data are insufficient to recommend one specific type over another for non-CMC joints. 1
Wear Duration - CRITICAL DETAIL
The orthosis must be worn continuously for a minimum of 3 months to achieve clinical benefit; shorter durations are ineffective. 2, 5 This is a common pitfall—patients who discontinue use before 3 months will not experience significant symptom relief. 2
Fitting and Evaluation
- Evaluation by an occupational therapist is strongly recommended to ensure proper fitting, maximize compliance, and provide comprehensive hand therapy. 1
- Custom fabrication improves adherence compared to off-the-shelf devices. 2, 5
Adjunct Therapies - Multimodal Approach
Exercise (STRONGLY RECOMMENDED)
- Structured exercise programs targeting joint mobility, muscle strength, and thumb base stability are essential and should be prescribed to all patients. 1, 2
- CMC-specific exercises differ from interphalangeal joint exercises and must be tailored accordingly—this is a critical distinction. 2, 5
- Supervised exercise programs yield better outcomes than unsupervised home programs. 1, 5
- Range of motion and strengthening exercises should be combined. 2, 6
Thermal Modalities (CONDITIONALLY RECOMMENDED)
- Heat therapy (paraffin wax or hot packs) applied before exercise sessions provides symptomatic relief with 77% recommendation strength. 2, 5
- Local heat application is more strongly supported than ultrasound (25% recommendation strength). 2
Joint Protection Education (STRONGLY RECOMMENDED)
- Training in joint protection techniques to minimize mechanical stress on affected joints should be provided to all patients. 2, 5
- Instruction in ergonomic principles and pacing activities reduces joint loading. 5, 6
Pharmacological Adjuncts
First-Line: Topical NSAIDs
- Topical NSAIDs are the preferred initial pharmacologic option due to moderate effect size (ES = 0.77) and no increased gastrointestinal risk versus placebo. 2, 5
- Topical agents are strongly preferred over systemic treatments for safety reasons, especially when few joints are affected. 2
Second-Line: Acetaminophen
- Acetaminophen up to 4g/day may be added if topical NSAIDs are insufficient, though efficacy is limited. 2, 5
Third-Line: Oral NSAIDs
- Oral NSAIDs should be used at the lowest effective dose for the shortest duration when topical agents fail. 2, 5
- In patients aged ≥75 years, avoid oral NSAIDs entirely; continue topical NSAIDs regardless of response. 2, 5
- For increased gastrointestinal risk, use non-selective NSAIDs plus gastroprotective agent or selective COX-2 inhibitor. 2
Fourth-Line: Intra-articular Corticosteroids
- Intra-articular corticosteroid injections are conditionally recommended for painful flares, particularly effective for the trapeziometacarpal joint. 2, 5
Self-Management and Education (STRONGLY RECOMMENDED)
- Self-efficacy and self-management programs are strongly recommended to help patients understand their condition and participate actively in care. 2, 5
- Mobile app-delivered interventions (combining exercise, education, and self-management) show significant improvements in hand function at 6 months and better pain control than usual care. 7
Treatment Algorithm
Initiate simultaneously: Custom-made CMC orthosis (≥3 months continuous wear) + supervised exercise program + joint protection education + heat therapy before exercises + topical NSAIDs. 2, 5
If inadequate response after 4-6 weeks: Add acetaminophen up to 4g/day. 2, 5
If still inadequate after 4-6 weeks: Short-term oral NSAIDs at lowest effective dose (avoid in age ≥75 years). 2, 5
For acute painful flares: Consider intra-articular corticosteroid injection, especially for CMC joint. 2, 5
If marked pain/disability persists after ≥6 months of comprehensive conservative management: Refer for surgical consultation (trapeziectomy with LRTI is gold standard). 2
Common Pitfalls and Caveats
- Premature discontinuation of orthosis: Benefits require minimum 3-month continuous wear; shorter periods show no benefit. 2, 5
- Generic exercise prescription: CMC exercises must differ from interphalangeal joint exercises—one-size-fits-all programs are inadequate. 2, 5
- Skipping topical NSAIDs: Oral NSAIDs should not be initiated before exhausting topical options due to superior safety profile. 2, 5
- Elderly patients: Topical NSAIDs must be maintained as first-line in patients ≥75 years; oral NSAIDs carry unacceptable systemic risks. 2, 5
- Poor orthosis fit: Prefabricated devices have lower compliance; custom fabrication by occupational therapist is preferred. 2, 5
- Coordination of care: Optimal bracing requires clinician familiarity with brace types, availability, and fitting expertise. 1
Rheumatoid Arthritis Considerations
While the evidence above focuses on osteoarthritis, conservative management principles (orthoses, exercise, joint protection) apply to early rheumatoid arthritis of the hand, though disease-modifying antirheumatic drugs (DMARDs) are the cornerstone of RA treatment and should not be delayed. 8, 6 Orthoses in RA provide symptomatic relief but do not modify disease progression.